Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,002 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04895735 | MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer | active not recruiting | Phase 2 | 45 | Mayo ClinicOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT06744595 | Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer | enrolling by invitation | N/A | 50 | Mayo ClinicOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT07188532 | Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial(BEAR) | recruiting | N/A | 141 | Mayo ClinicOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT03823144 | Intravital Microscopy in Human Solid Tumors | recruiting | N/A | 85 | Mayo ClinicOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT03855800 | Molecular Detection of Advanced Neoplasia in Pancreatic Cysts | recruiting | N/A | 800 | Mayo ClinicOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06071845 | Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples(SOS4C) | recruiting | N/A | 450 | Mayo ClinicOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT06783179 | Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement | recruiting | — | 150 | Mayo ClinicOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT07456852 | Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy | recruiting | Phase 1 / Phase 2 | 60 | Mayo ClinicOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT04692818 | 3D Ultrasound Breast Imaging | recruiting | N/A | 125 | Mayo ClinicOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06388122 | DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients | recruiting | — | 100 | Mayo ClinicOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06246955 | Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer | recruiting | N/A | 200 | Mayo ClinicOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT04640779 | Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma | completed | Phase 1 | 22 | Mayo ClinicOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT06723041 | Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy | recruiting | N/A | 78 | Mayo ClinicOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT04183218 | Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes | completed | — | 24 | Mayo ClinicOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT03570827 | Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy | completed | Phase 2 | 53 | Mayo ClinicOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT04572711 | Prospective Evaluation of Biliary Tissue Sampling With ERCP | completed | — | 327 | Mayo ClinicOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06271616 | Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant | terminated | Phase 2 | 2 | Mayo ClinicOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07000864 | A Study of Live Tumor Fragments of Surgical Resections | recruiting | — | 250 | Mayo ClinicOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05830838 | Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer(DAPPER) | active not recruiting | N/A | 50 | Mayo ClinicOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT06401889 | Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy | recruiting | — | 35 | Mayo ClinicOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT03624478 | Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery | completed | Phase 2 | 25 | Mayo ClinicOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT05497804 | Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial | active not recruiting | Phase 2 | 17 | Mayo ClinicOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT06058663 | Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma | recruiting | Phase 1 | 16 | Mayo ClinicOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT03941730 | Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer | active not recruiting | Phase 2 | 8 | Mayo ClinicOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT05541016 | De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA | recruiting | Phase 2 | 455 | Mayo ClinicOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT06997068 | Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population | recruiting | Phase 2 | 25 | Mayo ClinicOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT06566209 | FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis | terminated | — | 2 | Mayo ClinicOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07087860 | Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers(RECIPE-B1) | recruiting | Phase 2 | 70 | Mayo ClinicOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT04797039 | MRI-Guided Cryoablation for Focal Native Prostate Cancer | recruiting | — | 100 | Mayo ClinicOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT02908048 | Extracellular RNA Markers of Liver Disease and Cancer | terminated | — | 1,865 | Mayo ClinicOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03477539 | Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma | completed | Phase 2 | 49 | Mayo ClinicOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03506373 | Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia | terminated | Phase 2 | 21 | Mayo ClinicOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03035331 | Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 11 | Mayo ClinicOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT03554083 | Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma | completed | Phase 2 | 64 | Mayo ClinicOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT05755269 | Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women | terminated | — | 19 | Mayo ClinicOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT06625047 | Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy | completed | Phase 4 | 30 | Mayo ClinicOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06667726 | An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors | recruiting | Phase 2 | 47 | Mayo ClinicOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT02366286 | Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants | completed | — | 892 | Mayo ClinicOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT04856046 | Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer | active not recruiting | — | 36 | Mayo ClinicOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06326216 | Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer | active not recruiting | — | 98 | Mayo ClinicOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT04082520 | Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy | recruiting | Phase 2 | 42 | Mayo ClinicOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT04692324 | Cerebrospinal Fluid Biomarkers for Brain Tumors | recruiting | — | 400 | Mayo ClinicOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT05507541 | TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma | active not recruiting | Phase 2 | 10 | Mayo ClinicOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT06356272 | Oropharynx (OPX) Biomarker Trial | recruiting | — | 560 | Mayo ClinicOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT06386315 | Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma | recruiting | Phase 2 | 112 | Mayo ClinicOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT06965166 | Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer | recruiting | — | 200 | Mayo ClinicOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT05392946 | Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study | active not recruiting | Phase 1 / Phase 2 | 49 | Mayo ClinicOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT05917145 | ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma | recruiting | Phase 1 | 94 | Mayo ClinicOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT02646384 | Ovarian Tissue Cryopreservation in Children | active not recruiting | N/A | 100 | Mayo ClinicOTHER | 1 | Apr 20, 2026 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials